期刊文献+

心力衰竭患者脑钠素水平与心功能的关系 被引量:13

Correlations between the level of brain natriuetic peptide and cardiac function in patients with heart failure
下载PDF
导出
摘要 【目的】研究慢性心力衰竭患者血清脑钠素(BNP)浓度与心功能的关系。方法用酶联免疫吸附法(ELISA)测定62例慢性心力衰竭患者及20名健康对照组血清BNP浓度,采用多普勒超声心动图测定左室射血分数(LVEF)、左室短轴缩短率(FS)、左室舒张末内径(LVEDD),观察BNP水平与LVEF、FS、LVEDD的相关性。结果心衰组血清BNP浓度较对照组明显增高(P<0.01),各心衰组BNP水平差异有统计学意义,且BNP水平随NYHA分级升高而升高。BNP水平与LVEF及FS呈负相关(r=-0.62,r=-0.59,P<0.01),与LVEDD呈正相关(r=0.67,P<0.01)。结论血清CNP浓度可作为反映心功能状态的指标,并与心脏结构有关。 Objective To demonstrate the relations of the serume brain natriuretic peptide(BNP) concentration with cardiac function in patients with chronic heart failure . Methods The serume brain natriuretic peptide (BNP) concentration were measured with ELISA methods in 62 heart failure patients and 20 healthy persons as control. Doppler echocardiography was performed to determine left ventricular ejection fraction (LVEF), left ventricular fractional shortening(FS) and left ventricular end diastolic diameters (LVEDD).Observe the correlation of BNP with LVEF.FS.LVEDD. Results The serume BNP concentration was significantly increased in patients with chronic heart failure as compared with healthy subjects(P〈0.01 ),BNP levels were significantly increased in heart function classes according to NYHA. BNP concentration had a significant negative correlation with LVEF(r=-0.62, P〈0.01), FS(r=-0.59, P〈0.01)and positively correlated with LVEDD in patients with heart failure (r=0.67, P〈0.01 ). Conclusion The serume BNP concentration was good marker used to reflect cardiac function and had a close relationship with left ventricular structure.
出处 《中国心血管病研究》 CAS 2006年第8期571-573,共3页 Chinese Journal of Cardiovascular Research
基金 南通市社会发展基金资助(S5057)
关键词 心力衰竭 充血性 利钠肽 心房功能 心室功能 脑钠素 Heart failure, congestive Natriuretic peptide, brain Atrial function Ventricular function
  • 相关文献

参考文献11

  • 1[1]Sirithunyanont C,Leowattana W,Sukumalchantra Y,et al.Role of the plasma brain natriuetic peptide in differentiating patients with congestive heart failure from other diseases.J Med Assoc Thai,2003,86 (Suppl 1):S87-S95.
  • 2[2]Michaels AD,Andrew K,Madden JA,et al.Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.Circulation,2003,107:2697-2701.
  • 3[3]Vitovec B,Delgado R,Zewail A,et al.Prolonged QTc interval and high B-type natriuetic peptide levels together predict mortality in patients with advanced heart failure.Circulation,2003,107:1764-1769.
  • 4[4]Sudoh T,Kangawa K,Minamion N,et al.A natriuretic peptide in porcine brain.Nature,1988,322:78-81.
  • 5白梅.脑钠肽在心力衰竭诊治中的研究进展[J].中国心血管病研究,2005,3(4):312-314. 被引量:23
  • 6宋建平,沈冰,刘志华,蒋文平.利钠肽检测评价慢性充血性心力衰竭治疗反应[J].中华内科杂志,2003,42(5):306-308. 被引量:43
  • 7[7]Kawai K,Hata K,Tokaoka H,et al.Plasma brain natriuetic peptide as a nove therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy:a potential of hormoneguided treatment.Am Heart J,2001,141:925-932.
  • 8[8]Anan F,Takahashi N,Ooie H,et al.Candesartan,an angiotensin Ⅱ receptor blocker,improves left ventricular hypertrophy and resistance.Metabolism,2004,53:777-781.
  • 9[9]Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosjs of heart failure.N Engl J Med 2002,347:161-167.
  • 10李静宇,王宇航,杨志新.放免法测定血浆脑钠素水平诊断无症状性心力衰竭[J].中国卫生检验杂志,2000,10(4):454-455. 被引量:18

二级参考文献25

  • 1雷秉钧.临床科研设计、衡量与评价 第三讲 病因及因果关系的研究和评价[J].中国实用内科杂志,1994,14(12):750-752. 被引量:5
  • 2[1]Maisel AS, Koon J, Krishnaswamy P, et al. Utility of Bnatriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,141(3): 367-374
  • 3[2]Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol, 2001.,37:379-385
  • 4[3]McDonagh TA, Robb SD, Murdoch DR, et al.Biochemical detection of left -ventricular systolic dysfunction. Lancet, 1998, 351(9095): 9-13
  • 5[4]Groenning BA, Nilsson JC, Sonderguard L,,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail, 2001, 3(6):699-708
  • 6[5]Sagnella GA. Mearement and significance of circulating natriuretic peptide in cardiovascular disease. Clin Sci,1998, 95:519-529
  • 7[6]Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol, 2004, 43:55-60
  • 8[7]Lubien E, DeMaria A, Krishnaswany P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings. Circulation,2002, 105(5): 595-601
  • 9[8]Nicholls MG, Lainchbury JG, Richards AM, et al. Brain natriuretic peptide-guided therapy for heart failure.Nicholls MG, Lainchbury JG, Richards AM, Troughton RW, Yandle TG. Ann Med, 2001, 33(6): 422-427
  • 10[9]Murdoch DR, McDonagh TA, Byrne J, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration:randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J, 1999, 138(6Pt1): 1126-1132

共引文献80

同被引文献118

引证文献13

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部